Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 228 | $116,134,138 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,772 | 5.8421 | 45,405 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 946 | 5.8421 | 5,527 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,248 | 5.8409 | 42,335 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 883 | 5.8409 | 5,158 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 7,010 | 5.9874 | 41,972 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 827 | 5.9874 | 4,952 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 19,789 | 5.7415 | 113,619 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 2,334 | 5.7415 | 13,401 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 1,521 | 5.93 | 9,020 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 179 | 5.93 | 1,061 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 25 May 2022 | Purchase | 42,250 | 6.6036 | 279,002 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 25 May 2022 | Purchase | 4,984 | 6.6036 | 32,912 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 25 May 2022 | Purchase | 48,222 | 6.5335 | 315,058 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 25 May 2022 | Purchase | 5,688 | 6.5335 | 37,163 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 984 | 6.755 | 6,647 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 53,401 | 6.7512 | 360,521 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 116 | 6.755 | 784 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 6,299 | 6.7512 | 42,526 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 29,090 | 6.7064 | 195,089 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 26 May 2022 | Purchase | 3,432 | 6.7064 | 23,016 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 88,046 | 6.92 | 609,278 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 10,386 | 6.92 | 71,871 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 51,082 | 6.7806 | 346,367 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 6,026 | 6.7806 | 40,860 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 358 | 6.635 | 2,375 | I |
27 May 2022 16:44 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 May 2022 | Purchase | 42 | 6.635 | 279 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 2,364 | 5.8202 | 13,759 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 279 | 5.8202 | 1,624 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 02 Jun 2022 | Purchase | 138,122 | 7.6793 | 1,060,680 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 02 Jun 2022 | Purchase | 10,585 | 7.5144 | 79,540 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 02 Jun 2022 | Purchase | 16,278 | 7.6793 | 125,004 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 02 Jun 2022 | Purchase | 1,247 | 7.5144 | 9,370 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 03 Jun 2022 | Purchase | 78,271 | 7.9527 | 622,466 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 03 Jun 2022 | Purchase | 9,224 | 7.9527 | 73,356 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 03 Jun 2022 | Purchase | 13,155 | 7.9333 | 104,363 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 03 Jun 2022 | Purchase | 1,550 | 7.9333 | 12,297 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 26,450 | 6.4215 | 169,849 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 3,118 | 6.4215 | 20,022 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 7,815 | 6.3537 | 49,654 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 921 | 6.3537 | 5,852 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 06 Jun 2022 | Purchase | 170,549 | 7.7808 | 1,327,008 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 06 Jun 2022 | Purchase | 20,108 | 7.7808 | 156,456 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 06 Jun 2022 | Purchase | 101,315 | 7.7488 | 785,070 | I |
06 Jun 2022 17:08 | KOD | Kodiak Sciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 06 Jun 2022 | Purchase | 11,945 | 7.7488 | 92,559 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 40,632 | 24.8 | 1,007,674 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 3,781 | 24.8 | 93,769 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 82,148 | 24.4604 | 2,009,373 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 7,645 | 24.4604 | 187,000 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 74,582 | 25.54 | 1,904,824 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 6,941 | 25.54 | 177,273 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 116,672 | 25.3302 | 2,955,325 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 23 May 2023 | Purchase | 10,858 | 25.3302 | 275,035 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 259,109 | 25.65 | 6,646,146 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 24,113 | 25.65 | 618,498 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 28,878 | 25.5138 | 736,788 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 2,688 | 25.5138 | 68,581 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 218,171 | 25.2723 | 5,513,683 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 20,304 | 25.2723 | 513,129 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 1,740,581 | 0.6308 | 1,097,958 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 143,519 | 0.6308 | 90,532 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 207,676 | 0.6805 | 141,324 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 17,124 | 0.6805 | 11,653 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 61,134 | 0.6928 | 42,354 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 93,091 | 0.6924 | 64,456 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
23 Oct 2023 16:49 | BCEL | Atreca Inc | BAKER BROS. ADVISORS LP | Former 10% Owner | 19 Oct 2023 | Sale | 251,902 | 0.4025 | 101,391 | I |
23 Oct 2023 16:49 | BCEL | Atreca Inc | BAKER BROS. ADVISORS LP | Former 10% Owner | 19 Oct 2023 | Sale | 22,837 | 0.4025 | 9,192 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 26,426 | 146.2104 | 3,863,756 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,228 | 146.2104 | 325,757 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,994 | 145.9775 | 437,057 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 252 | 145.9775 | 36,786 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 6,369 | 145.4592 | 926,430 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 537 | 145.4592 | 78,112 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 1,291 | 142.8575 | 184,429 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 109 | 142.8575 | 15,571 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 10,790 | 141.445 | 1,526,192 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 910 | 141.445 | 128,715 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 5,072 | 140.9024 | 714,657 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 427 | 140.9024 | 60,165 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 4,631 | 137.6855 | 637,622 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,693 | 136.9089 | 505,605 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 390 | 137.6855 | 53,697 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 311 | 136.9089 | 42,579 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,144 | 136.1805 | 428,151 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 265 | 136.1805 | 36,088 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 13,548 | 154.7801 | 2,096,961 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 1,142 | 154.7801 | 176,759 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 683 | 153.9736 | 105,164 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 8,098 | 153.9736 | 1,246,878 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,877 | 153.2523 | 440,907 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 242 | 153.2523 | 37,087 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 646 | 152.2129 | 98,330 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 54 | 152.2129 | 8,219 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 6,022 | 152.48 | 918,235 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 507 | 152.48 | 77,307 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)